Table VII— Postoperative Transfusion of Blood Components According to Patient Group
and Percentage of Autologous Blood Transfused
Postoperative Transfus on of Blood Components
Percentage of
Autologous Blood
Transfused
% of
Patients
1%-25%
26%-50%
51%-75%
76%-99%
100%
0
17
17
0
0
Group
Group II
Group III
Group IV
Average No, of Units
Average No. of Units
Average Mo. of Units
Average No. of Units
FreshFrozen
Plasma
Platelet
Concentrate
2.5
2.0
1
1,3
transfusion: An underutilized
Surgery 80:474-479.
technique.
7. Deysine, M., 1977. Intraoperative autotransfusion and air embolism, letter. Surgery
81:729.
8. Raines. J., et al.. 1976. Intraoperative autotransfusion: Equipment, protocols, and guidelines. J. Trauma 16:616-623.
9. Aaron, R.K.. Beazley, R.M., and Riggle, G.C.,
Society
Spotlights
%0f
Patients
30
44
71
0
0
FreshFrozen
Plasma
Platelet
Concentrate
%ot
Patients
2.5
2.8
2.2
3.0
1.3
06
43
66
50
0
0
FreshFrozen
Plasma
Platelet
Concentrate
%of
Patients
5.6
6.1
3.3
2.0
6.5
2.0
0
100
100
50
0
1974. Hematologic integrity after intraoperative allotransfusion. Arch. Surg. 108:
831-837.
10. Wall, W,. et al., 1976. Intraoperative autotransfusion in major elective vascular operations: A clinical assessment. Surgery 79:
82-88.
11. McKenzie. FN., et al.. 1978. Intraoperative
autotransfusion in elective and emergency
vascular surgery Surgery 83:470-475.
FreshFrozen
Plasma
Platelet
Concentrate
6.0
6.7
50
2.0
4.3
7.0
12. Rakower, S.R., Worth, M.H., and Lackner,
H. 1973. Massive intraoperative autotransfusion of blood. Surg. Gynecol. Obstet.
137:633-636.
13. Relihan, M,, Olsen, R.E., and Litwin, M.S.,
1972. Clearance rate and effect on renal
function of stroma-free hemoglobin following renal ischemia. Ann. Surg. 176:
700-704.
•
Second Joint Conference of the
American Association for
Clinical Chemistry and the
American Society of Clinical
Pathologists
The Second Joint Conference of the American Association for Clinical Chemistry and the American
Society of Clinical Pathologists, titled "Recent A d vances in Cardiovascular Disease: Clinical and Diagnostic Aspects," will be held May 14-16, 1981, at
the Sheraton-Washington in Washington, D.C.
The conference will focus on promoting a better
understanding of the correct use of the clinical laboratory in the diagnosis of cardiovascular disease. The
various risk factors of heart disease, including hypertension, atherosclerosis, cholesterol levels, type A
behavior, alcohol consumption, n u t r i t i o n , exercise,
pregnancy and the pill, and diabetes and other
secondary disease states, will be discussed. The latest
clinical laboratory methods for monitoring the known
risk factors of cardiovascular disease and guidelines
for the proper ordering and interpretation of laboratory tests will be presented in lectures and panel
discussions.
For further information and registration forms,
contact Michele Tuttle, Meeting Manager, American
Association for Clinical Chemistry, 1725 K Street,
N.W., Washington, DC 20006.
•
LABORATORY MEDICINE • VOL. 12, NO. 3, MARCH 1981 1 7 1